• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 4, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Implementing post-genomic personalized medicine: The rise of glycan biomarkers

Bioengineer by Bioengineer
January 13, 2020
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Mary Ann Liebert, Inc., publishers


New Rochelle, NY, January 13, 2020–An in-depth look at the science of glycobiology and glycan diagnostics, and their promise in personalized medicine in the current post-genomic era are featured in a special issue of OMICS: A Journal of Integrative Biology, the peer-reviewed interdisciplinary journal published by Mary Ann Liebert, Inc., publishers. Click here to read the special issue on Glycomics and Personalized Glycomedicine free on the OMICS: A Journal of Integrative Biology website until February 15, 2020.

This special issue was co-edited by Wei Wang, MD, PhD, Edith Cowan University (Joondalup, Australia) and Capital Medical University (Beijing, China), and Vural Özdemir, MD, PhD, Editor-in-Chief of OMICS: A Journal of Integrative Biology. Dr. Wang and a team of researchers from Australia, China, and Croatia contributed an article entitled “Type 2 Diabetes Mellitus is Associated with the Immunoglobulin G N-Glycome through Putative Proinflammatory Mechanisms in an Australian Population.”) The team analyzed the N-glycan patterns of immunoglobulin G (IgG) in individuals with type 2 diabetes (T2D) and found novel associations between the IgG N-glycome, T2D, and clinical risk factors related to proinflammatory mechanisms. These IgG N-glycomic alterations offer promise as future biomarkers for T2D diagnosis or monitoring of progression to cardiovascular disease or renal failure.

A review article by Tanja Kunej, PhD University of Ljubljana (Domzale, Slovenia) is entitled “Rise of Systems Glycobiology and Personalized Glycomedicine: Why and How to Integrate Glycomics with Multiomics Science?” Dr. Kunej proposes that for glycomics to make a greater, systems-scale contribution to biology and medicine, it needs to transition from a single omics science to multiomics technology platforms. The article presents examples of glycomics in association with other omics fields, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics, and discusses current knowledge gaps and suggests future research directions.

Vural Özdemir, MD, PhD, Editor-in-Chief of OMICS: A Journal of Integrative Biology states: “Carbohydrates and glycans matter for personalized medicine. This OMICS special issue on glycomics and personalized glycomedicine signals the rise of glyco-theranostics as a new specialty in diagnostic medicine and systems science. It connects the dots between some of the most critical issues in biomarkers, post-genomic personalized medicine, and emerging technology governance to move systems science into clinical practice. Any reader interested in diagnostics in health care should benefit from reading the new OMICS issue curated with a systems approach to glycobiology and personalized/precision medicine.”

###

About the Journal

OMICS: A Journal of Integrative Biology is an authoritative and highly innovative peer-reviewed interdisciplinary journal published monthly online, addressing the latest advances at the intersection of postgenomics medicine, biotechnology and global society, including the integration of multi-omics knowledge, data analyses and modeling, and applications of high-throughput approaches to study complex biological and societal problems. Public policy, governance and societal aspects of the large-scale biology and 21st century data-enabled sciences are also peer-reviewed. Complete tables of content and a sample issue may be viewed on the OMICS: A Journal of Integrative Biology website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research, including Journal of Computational Biology, ASSAY and Drug Development Technologies, and Zebrafish. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Media Contact
Kathryn Ryan
[email protected]
914-740-2250

Original Source

https://home.liebertpub.com/news/implementing-post-genomic-personalized-medicine-the-rise-of-glycan-biomarkers/3645

Tags: BiologyDiabetesMedicine/HealthNutrition/Nutrients
Share12Tweet8Share2ShareShareShare2

Related Posts

Addressing Laboratory Errors in University Hospital

October 4, 2025
blank

αCGRP Deficiency Worsens Lung Fibrosis via Cell Aging

October 4, 2025

Key Skills for New ICU Nurses in Iran

October 4, 2025

Acylation Shapes Immunotherapy Success in Liver Cancer

October 4, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    93 shares
    Share 37 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    90 shares
    Share 36 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    69 shares
    Share 28 Tweet 17

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Addressing Laboratory Errors in University Hospital

Vasopressin vs Epinephrine: Pediatric Cardiac Arrest Outcomes

α-L-Fucosidase Isoenzymes: New Glioma Prognostic Markers

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.